Selera Medical was founded with the mission to revolutionize the treatment of chronic heart failure through innovative medical devices. The company focuses on developing a one-time, minimally invasive device that leverages the body's natural fluid management system to alleviate fluid overload, a primary cause of heart failure symptoms and hospitalizations. By improving patient health and reducing the need for recurrent hospital visits, Selera Medical aims to enhance the quality of life for millions affected by heart failure globally.

Notable affiliates and investors in Selera Medical include leading figures in the medical and venture capital communities, although specific names are not publicly disclosed. The company has achieved significant milestones in clinical trials, demonstrating the efficacy and safety of its device. Selera Medical's impact is marked by its potential to transform heart failure treatment, offering a sustainable solution that addresses both patient well-being and healthcare system burdens.